| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |